A Pillar in Kenya’s Advancing Healthcare
About IMIC
The Integrated Molecular Imaging Centre (IMIC) at Kenyatta University Teaching, Referral & Research Hospital (KUTRRH) continues to play a crucial role in cancer diagnosis and treatment through advanced nuclear medicine. Located within one of Kenya’s most advanced medical facilities, IMIC is a hub of innovation, diagnostics, and patient-centered care.
Highlight Visit: Government Spokesperson’s Office
A recent high-profile visit to IMIC saw a delegation from the Government Spokesperson’s Office led by Ms. Lydia Rosasi, documenting the impact of nuclear medicine in healthcare.
The KUTRRH team was represented by:
- Dr. Isaiah Gituma – Director of Finance, Planning, and Development
- Dr. Harish Nagaraj – Ag. Incharge, IMIC
- Ms. Emma Mwongera – Corporate Communications & Marketing Manager
The tour was aimed at showcasing how IMIC contributes to timely and accurate diagnosis, especially in oncology, and how it aligns with the hospital’s broader mission of excellence in healthcare and research.
Nuclear Medicine in Action
IMIC uses advanced molecular imaging technologies such as:
- PET-CT (Positron Emission Tomography – Computed Tomography)
- SPECT (Single Photon Emission Computed Tomography)
- Gamma Cameras
These allow physicians to visualize and understand complex conditions like cancer, cardiovascular diseases, and neurological disorders at a molecular level—enabling more targeted treatment plans.
Strategic Role
IMIC supports:
- Early cancer detection
- Monitoring of treatment progress
- Personalized therapy plans
- Non-invasive diagnostic approaches
Its role is aligned with KUTRRH’s vision to provide world-class healthcare through technological innovation and clinical excellence.
In the Spotlight
“The visit by the Government Spokesperson’s team underscores national recognition of nuclear medicine’s transformative impact. IMIC stands as a beacon of progress in Kenya’s public healthcare.”
— Dr. Harish Nagaraj, Acting Incharge, IMIC
